NUS

$4.70-1.67%visit website

NU SKIN ENTERPRISES, INC.

Market Cap

$229M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Wholesale-Drugs, Proprietaries & Druggists' Sundries

Beta (raw)

0.91

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.2

TTM to Jun 2026 · revenue

P/B

0.4

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

6.3

TTM to Jun 2026 · EV incl. net debt

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	364,211	370,320	320,608	320,112	1,375,251
Cost of revenue	107,488	108,339	106,145	101,787	423,759
Gross profit	256,723	261,981	214,463	218,325	951,492
Total operating expenses	235,081	238,737	210,437	277,644	961,899
Operating income	21,642	23,244	4,026	(59,319)	(10,407)
Interest expense	4,145	3,994	4,250	3,322	15,711
Pretax income	15,994	18,191	2,599	(63,175)	(26,391)
Income tax	(1,085)	3,700	763	186,623	190,001
Net income	17,079	14,491	1,836	(249,798)	(216,392)
EPS (basic) ($)	0.35		0.04	(5.14)	(4.46)
EPS (diluted) ($)	0.34		0.04	(5.14)	(4.53)
Weighted avg. shares (basic)	49,398		48,202	48,596
Weighted avg. shares (diluted)	50,310		49,422	48,596

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 10, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 65 more quarters, back to Jun 2009, with Tormere Pro.

Corporate Events (8-K)

10 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 21, 2026 accepted 4:06 PM ET	5.02Officer / director change	Document SEC ↗
Aug 10, 2026 accepted 4:15 PM ET	2.02Earnings release	Document SEC ↗
May 29, 2026 accepted 4:05 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 8, 2026 accepted 4:06 PM ET	5.02Officer / director change	Document SEC ↗
May 7, 2026 accepted 5:09 PM ET	2.02Earnings release	Document SEC ↗
Mar 27, 2026 accepted 4:34 PM ET	1.01Material agreement2.03New debt obligation	Document SEC ↗
Mar 20, 2026 accepted 4:16 PM ET	5.02Officer / director change	Document SEC ↗
Mar 9, 2026 accepted 4:16 PM ET	5.02Officer / director change	Document SEC ↗
Feb 12, 2026 accepted 4:23 PM ET	2.02Earnings release	Document SEC ↗
Nov 6, 2025 accepted 4:26 PM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

58%

W/W +17.2pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-02	2026-06-03	Winett James M	Director	Sale	7,203	$5.62	$40K	37.4K	View
2026-06-01	2026-06-03	WOODBURY EDWINA D	Director	Sale	7,203	$5.70	$41K	62.4K	View
2026-05-11	2026-05-12	Nathanson Laura	Director	Sale	2,676	$6.73	$18K	30.5K	View
2025-09-04	2025-09-04	Nathanson Laura	Director	Sale	6,489	$12.22	$79K	33.1K	View